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nimal models are important in investigating the
origin and the mechanisms underlying a human disease
and designing new therapies,and have been widely used
in various areas of medical research.Animal models have
not been,however,very popular in psychiatric research.
Reproducing psychiatric disorders in animals has often
been considered difficult, if not impossible. Modeling
schizophrenia is an example of a particularly difficult task,
because it is a uniquely human disease, and its most
prominent symptoms—hallucinations, delusions, and
thought disorder—cannot be reproduced in an animal.
Recent new evidence about the neurobiology of this dis-
ease has opened new possibilities of animal research.In
particular,abnormalities in the neural circuitry involving
the hippocampus,prefrontal cortex,and the dorsomedial
thalamus have been reported recently,in addition to pre-
viously recognized abnormal function of the dopaminer-
gic system.Cytoarchitectural and molecular studies of the
brain,as well as neuropsychological studies showing that
schizophrenia symptoms emerge in young adulthood but
subtle motor and behavioral abnormalities are present
early in life,suggest a neurodevelopmental origin of the
disease.
To address a neurodevelopmental origin of schizophrenia,
numerous studies modeling schizophrenia in animals have
focused on neonatal damage of restricted brain regions in
rats
1-11 and in monkeys.
12-15The main objective of many of
these studies is to disrupt development of the hippocam-
pus,a brain area consistently implicated in human schizo-
phrenia,
16-25 and thus disrupt development of the wide-
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In the context of our current knowledge about schizo-
phrenia, heuristic models of psychiatric disorders may be
used to test the plausibility of theories developed on the
basis of new emerging biological findings, explore mech-
anisms of schizophrenia-like phenomena, and develop
potential new treatments. In a series of studies, we have
shown that neonatal excitotoxic lesions of the rat ventral
hippocampus (VH) may serve as a heuristic model. The
model appears to mimic a spectrum of neurobiological
and behavioral features of schizophrenia, including func-
tional pathology in presumably critical brain regions inter-
connected with the hippocampal formation and targeted
by antipsychotic drugs (the striatum/nucleus accumbens
and the prefrontal cortex), and leads in adolescence or
early adulthood to the emergence of abnormalities in a
number of dopamine-related behaviors. Moreover, our
data show that even transient inactivation of the VH dur-
ing a critical period of development, which produces sub-
tle, if any, anatomical changes in the hippocampus, may
be sufficient to disrupt normal maturation of the pre-
frontal cortex (and perhaps, other interconnected late-
maturing regions) and trigger behavioral changes similar
to those observed in animals with the permanent excito-
toxic lesion. These results represent a potential new model
of aspects of schizophrenia without a gross anatomical
lesion. 
Dialogues Clin Neurosci. 2002;4:361-367.spread cortical and subcortical circuitry in which the hip-
pocampus participates. The lesions were intended to
involve regions of the hippocampus that directly project
to the prefrontal cortex,ie,ventral hippocampus (VH) and
ventral subiculum,
26,27 and that correspond to the anterior
hippocampus in humans,a region that shows anatomical
abnormalities in schizophrenia.
21Valid models would be
expected to mimic a wide array of behavioral aspects of
the human disorder (Table I).
Neonatal excitotoxic VH lesions alter 
development of prefrontal cortex
In a series of studies,we have shown that neonatal excito-
toxic lesions of the rat VH lead in adolescence to the
emergence of abnormalities in a number of dopamine-
related behaviors.
28 When tested as juveniles (postnatal
day 35 [PD35]),rats with the neonatal VH lesions are less
social than controls,
29 but otherwise behave normally in
motor tests involving exposure to stress and dopamine
agonists.In adolescence and adulthood (PD56 and older),
lesioned animals display marked changed behaviors
thought to be primarily linked to increased mesolimbic/
nigrostriatal dopamine transmission (motor hyperrespon-
siveness to stress and stimulants,enhanced stereotypies).
They also show enhanced sensitivity to glutamate anta-
gonists (MK-801 and phencyclidine [PCP]), deficits in 
prepulse inhibition (PPI) and latent inhibition,impaired
social behaviors, and working memory problems,
9,10,30-38
phenomena showing many parallels with schizophrenia
(Figure 1).
37
Emergence of the behavioral changes in adolescence
appears not to be related to the surge of gonadal hor-
mones during puberty because a similar temporal pattern
of abnormalities is observed in animals depleted of
gonadal hormones prior to puberty.
32 Notably,removal of
prefrontal neurons in adult animals with the earlier hip-
pocampal lesion restores some of the behaviors (ie,those
modulated by, but not critically dependent on, the pre-
frontal cortex,such as hyperlocomotion after ampheta-
mine),suggesting that aberrant development of the pre-
frontal cortex in the context of early damage to the
hippocampus may be a critical factor in the expression of
the syndrome.
39 In this context,it is important to empha-
size that anatomical findings from postmortem studies and
neuropsychological and neuroimaging studies of brain
function in patients with schizophrenia have implicated
prefrontal cortical maldevelopment and a developmental
disconnection of the temporolimbic and prefrontal cor-
tices.
40Although the exact mechanisms of a seemingly sim-
ilar disconnection and malfunction of the prefrontal cor-
tex in the VH-lesioned rats need to be elucidated,
preliminary findings from molecular and electrophysio-
logical studies (such as reduced cortical levels of N-acetyl-
aspartate [NAA], attenuated stress-induced cortical
dopamine release, attenuated cortical expression of a
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Selected abbreviations and acronyms
BDNF brain-derived neurotrophic factor
DAT dopamine transporter
GABA γ-aminobutyric acid
GAD67 glutamate decarboxylase-67
NAA N-acetylaspartate 
PD postnatal day
PPI prepulse inhibition
TTX tetrodotoxin
VH ventral hippocampus
VTA ventral tegmental area
Table I. Clinical aspects of schizophrenia and relevant behavioral changes in an animal model. DA, dopamine; NMDA, N-methyl-D-aspartate; PPI, pre-
pulse inhibition.
Schizophrenia Animal model
Psychotic symptoms Behaviors related to increased DA transmission
Stereotypic behaviors Dopamimetic-induced stereotypy
Worsening of symptoms by NMDA antagonists NMDA antagonist–induced hyperlocomotion
Vulnerability to stress Stress-induced hyperlocomotion
Improvement of psychotic symptoms by neuroleptics Reduction of hyperlocomotion by neuroleptics 
Information-processing deficits Sensorimotor gating (PPI) deficits
Attention deficits Deficits in latent inhibition
Cognitive deficits Impaired performance in delayed alternation and spatial memory tasks
Social withdrawal Reduced contacts with unfamiliar partners
Anhedonia Diminished sensitivity to rewarding stimulimembrane glutamate transporter EAAC1 and of a syn-
thetic enzyme for γ-aminobutyric acid [GABA],glutamate
decarboxylase-67 [GAD67],reduced brain-derived neu-
rotrophic factor [BDNF] expression, altered cortical
expression of transcription factors,c-fos and ∆fosB,as well
as altered firing pattern of cortical pyramidal neurons in
response to ventral tegmental area [VTA] stimulation)
suggest that aberrant cortical dopamine/glutamate/GABA
interactions may underlie cortical dysfunction in neona-
tally VH-lesioned rats.
34,41-44
We have recently reported that excitotoxic prefrontal cor-
tical lesions in adult animals cause downstream striatal
NAA losses and reduced GAD-67 mRNA expression,and
suggested that both changes might reflect transsynaptic
pathology.
45 It is possible that similar transsynaptic events
occur in response to the neonatal VH lesion,but further
work is required to determine if,and by what mechanisms,
molecular changes in prefrontal neurons are linked.
Neonatal VH lesions mimic aspects of 
psychostimulant sensitization
It is interesting to note that many of these changes have
been reported in stress- and psychostimulant-sensitization
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Figure 1. Effects of the glutamate antagonist MK-801 (0.05 [MK0.05], 0.1 [MK0.1], and 0.2 [MK0.2] mg/kg) on locomotion (A) and stereotypy (B)
in sham and ventral hippocampus (VH)–lesioned rats. Rats were lesioned as neonates at postnatal day 7 and tested at three ages: 35, 65,
and 150 days. At all ages tested, only the highest dose of MK-801 (0.2 mg/kg) significantly increased locomotion (total distance traveled in
cm) in the sham-operated rats as compared with the saline injection. In the lesioned rats, only 0.2 mg/kg MK-801 significantly increased loco-
motion at postnatal days 35 and 65, but all three doses were effective at 150 days of age as compared with saline. Neonatally lesioned
animals showed significantly more locomotion and stereotypies than controls at days 65 and 150, but not at day 35. *Significantly higher
than controls that received the same dose of MK-801 (P<0.05); sham n=5 per dose group; lesion n=6 per dose group. 
Reproduced from reference 37: Al-Amin HA, Weickert CS, Lillrank SM, Weinberger DR, Lipska BK. Delayed onset of enhanced MK-801–induced motor hyperactivity after neonatal lesions
of the rat ventral hippocampus. Biol Psychiatry. 2001;49:528-539. Copyright © 2001, Elsevier Science.models,
46-48 as well as in patients with schizophrenia.
49,50
Subcortical function in the neonatally lesioned rats is also
altered in a fashion consistent with at least some reports
on behavioral sensitization,
51-54 ie,striatal dopamine release
is attenuated in response to stress and amphetamine,mid-
brain expression of the membrane dopamine transporter
(DAT) mRNA is reduced,striatal expression of dynorphin
(an opioid peptide colocalized with dopamine D1 recep-
tors) and ∆fosB (a transcription factor sensitive to persis-
tent stimulation) is enhanced.
42,55 It should be noted,how-
ever, that enhanced rather than attenuated striatal
dopamine release has been observed in other paradigms
of sensitization to psychostimulants,
56 as well as in a sub-
group of patients with schizophrenia as evidenced by
recent single-photon emission computed tomography
(SPECT) studies.
57-59 Similarly discrepant are the findings
of synaptic morphology:increased synaptic densities,num-
ber of branches,and dendritic length are reported in pre-
frontal cortex in sensitization models,
60 whereas these den-
dritic parameters are decreased in schizophrenia
61 and in
the neonatal hippocampal lesion model.
62 Nevertheless,an
array of behavioral and molecular changes associated with
this model suggest that early developmental insult of the
VH may facilitate sensitization of the dopamine system,
and thereby account for the adult onset of a maladaptive
condition characterized by a variety of dopamine-related
abnormalities. Similar pathophysiological mechanisms
have been hypothesized to underlie schizophrenia.
63-65
Unlike psychostimulant-sensitization models,however,the
neonatal lesion model does not target the dopamine sys-
tem directly and similar sensitization-like phenomena are
not seen following an analogous hippocampal lesion in
adult animals.It may be of considerable heuristic interest
to determine how the developmental lesion initiates the
subsequent behavioral and molecular phenomena associ-
ated with sensitization.
In terms of the predictive validity of the neonatal VH
lesion model,antipsychotic drugs normalize some lesion-
induced behaviors.
29,31 Drugs targeting the glutamate sys-
tem may also prove beneficial; LY293558, an aminoiso-
propyl propionic acid (AMPA) antagonist, is highly
efficient in blocking hyperlocomotion in the neonatally
lesioned rats at doses that do not affect locomotor activity
in controls,
36 as is the glycine transporter inhibitor.
66Thus,
this model may have predictive validity and heuristic
potential to identify drugs with new mechanisms of action.
The model also appears to mimic a spectrum of neuro-
biological and behavioral features of schizophrenia,includ-
ing functional pathology in presumably critical brain
regions interconnected with the hippocampal formation
and targeted by antipsychotic drugs:the striatum/nucleus
accumbens and the prefrontal cortex.It is noteworthy that
in the nonhuman primate,early postnatal damage of the
hippocampal region also alters development of the dorsal
prefrontal cortex and the mechanisms whereby the dorsal
prefrontal cortex regulates subcortical dopamine function,
phenomena similar to those described in patients with
schizophrenia.
13,14,67 Thus, neonatal damage to the hip-
pocampus of the rat appears to reproduce a broad spec-
trum of schizophrenia-related phenomena (Table I),and
establishes the neurobiological plausibility of early dam-
age having a delayed impact on neural functions impli-
cated in schizophrenia.
Transient VH inactivation model
Although developmental lesion models represent a rather
crude technique to study the role of particular brain
regions,transmitter systems,or the connections between
them,they have confirmed the plausibility of neurodevel-
opmental damage having selected deleterious effects after
a prolonged period of relative normalcy.In this respect,
they appear to have face validity not just in terms of
behavioral,cellular,and pharmacological phenomena,but
also in terms of the temporal course of the clinical disor-
der.As models of developmental pathology,they certainly
lack construct validity,as the schizophrenic brain does not
manifest a “lesion”analogous to any of these models;but
they may have heuristic value in discovering molecular
consequences of early brain damage and new treatment
strategies.
In the next series of studies,we hypothesized that transient
inactivation of the VH during a critical period of develop-
ment,that produces subtle,if any,anatomical changes in
the hippocampus,may be sufficient to disrupt normal mat-
uration of the prefrontal cortex (and perhaps,other inter-
connected late maturing regions).We explored whether
this developmental disruption would, in turn, trigger
behavioral changes similar to those observed in animals
with the permanent excitotoxic lesion. We used
tetrodotoxin (TTX),a potent and specific blocker of the
voltage-gated sodium channels, whose action is fully
reversible,to inactivate VH on PD7,an important time for
refinement of intracortical connections,and then assessed
behavioral changes that this infusion might have evoked
later in life,in juvenile (PD35) and young adult (PD56)
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68The overall characteristics of behavioral changes and
their temporal pattern were reminiscent of the distur-
bances associated with the permanent excitotoxic lesion
of the VH produced at the same neonatal age (Figure
2).
40,68 Neonatally TTX-infused rats displayed adulthood
motor hyperactivity upon pharmacological stimulation
(amphetamine and MK-801) and after stress of novelty
and a saline injection as compared with sham controls.The
magnitude of TTX-induced behavioral disruptions was
smaller,however,than those observed after the excitotoxic
lesion (eg,ibotenic acid lesions of the VH increased spon-
taneous and amphetamine-induced locomotor activity by
approximately 50% as compared with controls,
30,33,34
whereas TTX produced increases by about 15% to 20%).
Moreover,in contrast to the permanent lesion,TTX infu-
sions did not significantly affect social behaviors,although
a trend for reduced social interactions mimicked again a
pattern seen after the permanent lesions.Analogous TTX
infusions in adult animals did not alter these behaviors
later in life.It is unclear how such a transient and restricted
blockade of ventral hippocampal activity in neonatal life
can permanently alter brain function.One possibility is
that neonatal blockade impacts on the development of
neurons in the hippocampal formation and interconnected
systems that also undergo important maturational changes
at this time.These data suggest that transient loss of VH
function during a critical time in maturation of intracor-
tical connections permanently changes development of
neural circuits mediating certain dopamine- and N-methyl-
D-aspartate (NMDA)–related behaviors.These results rep-
resent a potential new model of aspects of schizophrenia
without a gross anatomical lesion. ❏
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Figure 2. Locomotor activity (total distance traveled) in rats with neona-
tal tetrodotoxin (TTX) infusions. Rats were tested in photocell
monitors at postnatal day 35 (PD35) and 56 (PD56) after expo-
sure to novelty (Nov), after saline injection (Sal), and ampheta-
mine administration (AMPH, 1.5 mg/kg, IP). TTX-infused rats
were significantly more active than sham rats (*P<0.05; n=13
to 16 per group). 
Reproduced from reference 68: Lipska BK, Halim ND, Segal PN, Weinberger DR.
Effects of reversible inactivation of the neonatal ventral hippocampus on behav-
ior in the adult rat. J Neurosci. 2002;22:2835-2842. Copyright © 2002, Society
for Neuroscience.
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Desconexión neonatal del hipocampo de la
rata: un modelo de neurodesarrollo en la
esquizofrenia
En el contexto de nuestro conocimiento actual
acerca de la esquizofrenia, los modelos heurísticos
de los trastornos mentales pueden ser utilizados
para probar la plausibilidad de las teorías desarro-
lladas a partir de los nuevos hallazgos biológicos
que están emergiendo, para explorar los mecanis-
mos de los fenómenos tipo-esquizofrenia y para
desarrollar potenciales nuevos tratamientos. En una
serie de estudios, nosotros hemos mostrado que las
lesiones excitotóxicas neonatales del hipocampo
ventral (HV) de la rata pueden servir como modelo
heurístico. El modelo parece semejar un espectro
de características neurobiológicas y conductuales
de la esquizofrenia, incluyendo patología funcio-
nal en regiones cerebrales presumiblemente críti-
cas, interconectadas con la formación del hipo-
campo y blancos de fármacos antipsicóticos (el
estriado/núcleo accumbens y la corteza prefrontal),
y conduce en la adolescencia o inicio de la adultez
a la aparición de anormalidades en diversas con-
ductas que se relacionan con la dopamina. Sin
embargo, nuestros datos muestran que incluso una
inactivación transitoria del HV durante un período
crítico del desarrollo, la cual puede producir cam-
bios anatómicos sutiles del hipocampo, puede ser
suficiente para alterar la maduración normal de la
corteza prefrontal (y tal vez otras regiones inter-
conectadas de maduración tardía) y provocar cam-
bios conductuales similares a los observados en ani-
males con lesiones excitotóxicas permanentes. Estos
resultados representan un potencial nuevo modelo
de aspectos de la esquizofrenia sin una gran lesión
anatómica.
Déconnexion néonatale de l’hippocampe 
de rat : un modèle de développement 
neurologique de la schizophrénie
Dans le contexte de nos connaissances actuelles sur
la schizophrénie, des modèles heuristiques des
troubles psychiatriques peuvent être utilisés pour
vérifier que les théories fondées sur la base des
nouvelles découvertes biologiques sont plausibles,
explorer les mécanismes de manifestations ana-
logues à la schizophrénie et développer de nou-
veaux traitements potentiels. Dans une série
d’études, nous avons montré que les lésions exci-
totoxiques néonatales de l’hippocampe ventral du
rat (HV) peuvent servir de modèle heuristique. Ce
modèle semble mimer un faisceau de particularités
neurobiologiques et comportementales de la schi-
zophrénie, y compris la pathologie fonctionnelle
dans des régions cérébrales sans doute cruciales,
interconnectées avec la formation hippocampique
et ciblées par les médicaments antipsychotiques (le
striatum/noyau accumbens et le cortex préfrontal),
conduisant dans l’adolescence ou au début de l’âge
adulte à l’apparition d’anomalies dans un certain
nombre de comportements en relation avec la
dopamine. De plus, nos données montrent que
même une inactivation transitoire de l’HV pendant
une période-clé du développement, qui produit des
changements anatomiques subtils de l’hippocampe,
s’il y en a, peut être suffisante pour interrompre la
maturation normale du cortex préfrontal (et peut-
être d’autres régions interconnectées à maturation
tardive) et entraîner des changements comporte-
mentaux semblables à ceux observés chez l’animal
ayant une lésion excitotoxique permanente. Ces
résultats constituent un nouveau modèle potentiel
des aspects de la schizophrénie sans lésion anato-
mique marquée.A neurodevelopmental model of schizophrenia - Lipska Dialogues in Clinical Neuroscience - Vol 4 . No.4 . 2002
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